Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 3
2008 1
2014 1
2015 1
2016 2
2017 4
2019 1
2020 8
2021 9
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Application of microarray-based technology to neuroblastoma.
Scaruffi P, Valent A, Schramm A, Astrahantseff K, Eggert A, Tonini GP. Scaruffi P, et al. Among authors: astrahantseff k. Cancer Lett. 2005 Oct 18;228(1-2):13-20. doi: 10.1016/j.canlet.2005.01.052. Cancer Lett. 2005. PMID: 15951106 Review.
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review.
Van Paemel R, Vlug R, De Preter K, Van Roy N, Speleman F, Willems L, Lammens T, Laureys G, Schleiermacher G, Tytgat GAM, Astrahantseff K, Deubzer H, De Wilde B. Van Paemel R, et al. Among authors: astrahantseff k. Eur J Pediatr. 2020 Feb;179(2):191-202. doi: 10.1007/s00431-019-03545-y. Epub 2020 Jan 3. Eur J Pediatr. 2020. PMID: 31897843 Free PMC article. Review.
Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.
Arlt B, Zasada C, Baum K, Wuenschel J, Mastrobuoni G, Lodrini M, Astrahantseff K, Winkler A, Schulte JH, Finkler S, Forbes M, Hundsdoerfer P, Guergen D, Hoffmann J, Wolf J, Eggert A, Kempa S, Deubzer HE. Arlt B, et al. Among authors: astrahantseff k. Int J Cancer. 2021 Mar 1;148(5):1219-1232. doi: 10.1002/ijc.33423. Epub 2020 Dec 17. Int J Cancer. 2021. PMID: 33284994
Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt Vv, Sieverts H, Kuhfittig-Kulle S, Pfeiffer P, Versteeg R, Eggert A. Schramm A, et al. Among authors: astrahantseff k. Cancer Lett. 2005 Oct 18;228(1-2):143-53. doi: 10.1016/j.canlet.2005.02.051. Cancer Lett. 2005. PMID: 15921851 Review.
Health outcomes in offspring born to survivors of childhood cancers following assisted reproductive technologies.
Sommerhäuser G, Borgmann-Staudt A, Astrahantseff K, Baust K, Calaminus G, Dittrich R, Fernández-González MJ, Hölling H, König CJ, Schilling R, Schuster T, Lotz L, Balcerek M. Sommerhäuser G, et al. Among authors: astrahantseff k. J Cancer Surviv. 2021 Apr;15(2):259-272. doi: 10.1007/s11764-020-00929-0. Epub 2020 Aug 26. J Cancer Surviv. 2021. PMID: 32844376 Free PMC article.
ALK pERKs up MYCN in neuroblastoma.
Lindner S, Henssen A, Astrahantseff K, Schulte JH. Lindner S, et al. Among authors: astrahantseff k. Sci Signal. 2014 Oct 28;7(349):pe27. doi: 10.1126/scisignal.2005940. Sci Signal. 2014. PMID: 25351246
Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction.
Peitz C, Sprüssel A, Linke RB, Astrahantseff K, Grimaldi M, Schmelz K, Toedling J, Schulte JH, Fischer M, Messerschmidt C, Beule D, Keilholz U, Eggert A, Deubzer HE, Lodrini M. Peitz C, et al. Among authors: astrahantseff k. J Mol Diagn. 2020 Nov;22(11):1309-1323. doi: 10.1016/j.jmoldx.2020.07.006. Epub 2020 Aug 26. J Mol Diagn. 2020. PMID: 32858250 Free article.
Mutational dynamics between primary and relapse neuroblastomas.
Schramm A, Köster J, Assenov Y, Althoff K, Peifer M, Mahlow E, Odersky A, Beisser D, Ernst C, Henssen AG, Stephan H, Schröder C, Heukamp L, Engesser A, Kahlert Y, Theissen J, Hero B, Roels F, Altmüller J, Nürnberg P, Astrahantseff K, Gloeckner C, De Preter K, Plass C, Lee S, Lode HN, Henrich KO, Gartlgruber M, Speleman F, Schmezer P, Westermann F, Rahmann S, Fischer M, Eggert A, Schulte JH. Schramm A, et al. Among authors: astrahantseff k. Nat Genet. 2015 Aug;47(8):872-7. doi: 10.1038/ng.3349. Epub 2015 Jun 29. Nat Genet. 2015. PMID: 26121086
28 results